Page last updated: 2024-11-02

oxprenolol and Primary Myelofibrosis

oxprenolol has been researched along with Primary Myelofibrosis in 1 studies

Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.

Research Excerpts

ExcerptRelevanceReference
"The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed."1.27Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. ( Ben Arieh, Y; Brenner, B; Green, J; Nagler, A; Rosenbaum, H; Tatarsky, I, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, B1
Green, J1
Rosenbaum, H1
Ben Arieh, Y1
Nagler, A1
Tatarsky, I1

Other Studies

1 other study available for oxprenolol and Primary Myelofibrosis

ArticleYear
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.
    Acta haematologica, 1985, Volume: 74, Issue:1

    Topics: Angina Pectoris; Humans; Immunoblastic Lymphadenopathy; Oxprenolol; Pancytopenia; Prednisone; Primar

1985